NCT05194436

Brief Summary

The primary objective of this study is to determine if Aevice Medical Device can detect wheeze as accurately as a physician through auscultation. The secondary objective is to investigate if Aevice Medical Device can be used for remote auscultation of the lung.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 23, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 18, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2024

Completed
Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

2.2 years

First QC Date

December 17, 2021

Last Update Submit

May 29, 2025

Conditions

Keywords

WheezeAuscultation

Outcome Measures

Primary Outcomes (1)

  • Wheeze is detected by physician and AeviceMD

    Primary end point of wheeze will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation. AeviceMD will perform wheeze analysis on each 5 sec of recording

    60 Seconds

Secondary Outcomes (1)

  • Respiratory sounds are detected and identified by onsite physician and offsite (remote) physician

    150 Seconds

Interventions

AeviceMDDEVICE

The AeviceMD will be placed on the patient to detect wheeze and perform auscultation.

Also known as: AeviceMD Monitoring System

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Study will include 35 patients who are admitted for exacerbations of chronic airway disease (i.e. Asthma)

You may qualify if:

  • The subject is willing and parents/guardians are able to give informed consent for participation in the study.
  • Male or Female, aged 3 -18 years.
  • Presenting with wheeze.
  • Able (in the Investigators opinion) and willing to comply with all study requirements

You may not qualify if:

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital

Singapore, Singapore, 119074, Singapore

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveAsthmaRespiratory Sounds

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchial DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesSigns and Symptoms, RespiratorySigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2021

First Posted

January 18, 2022

Study Start

April 23, 2021

Primary Completion

July 18, 2023

Study Completion

July 18, 2024

Last Updated

June 4, 2025

Record last verified: 2025-05

Locations